INCA Global NET Patient Advocate Summit 2024: Best Practices Exchange on Improvement of NET Awareness and Outcomes for Patients
The 12th INCA Global NET Patient Advocate Summit took place in Segovia, Spain, on 9th – 10th September 2024. Over 30 representatives of INCA member organizations across the globe, together with the ENETS and NANETS leaders, as well as neuroendocrine cancer advocacy...
Driving Change Takes Knowledge and Skills
Stephanie Alband, INCA President (Pheo Para Alliance, USA), Duncan Macduff, INCA Communications Committee Chair (NETSAS, South Africa) and Dirk Van Genechten (vzw NET & MEN Kanker Belgium) were delighted to take part in the WECAN Masterclass. WECAN Academy 2024...
Focus on Timely and Equal Patient Access to Innovative Oncology Drugs Across Europe
INCA Executive Director Teodora Kolarova brought the cancer patient perspective at the insightful workshop on “Clinical Research in Central and Eastern Europe: New Approaches for the Next Level of Development”, organized by Cancer Drug Development Forum (CDDF) on...
INCA Annual General Meeting 2024 Elected Two New Board Members
On April 9th, 2024, the INCA Annual General Meeting (AGM) 2024 convened the full INCA Membership to reflect on the reported achievements in 2023 and build on priorities and plans going forward. The elections for two new members of the Board of Directors took place...
2024 INCA/ENETS Symposium: Challenges and Strategies of Engaging Non-NEN Healthcare Professionals in Understanding NENs
The Annual INCA/ENETS Symposium on March 15th, 2024, showcased the joint strategy of patient advocates and ENETS experts in reaching out to educate primary care physicians and other medical specialists in neuroendocrine neoplasms detection and patient management. The...
INCA is a non-profit 501(c)3 organization incorporated in 2013.
